Chiron Real Estate Inc. 8K

Chiron Real Estate furnished its Q2 2026 earnings supplemental on Form 8‑K, detailing strong net income from asset sales, capital raising via a new convertible preferred issue, expansion into seniors housing and multiple JV/loan investments and dispositions, along with updated leverage metrics and a key tenant bankruptcy update.

Chiron Real Estate (NYSE: XRN) filed a Form 8‑K to furnish its Q2 2026 earnings supplemental, reporting a sharp swing to net income attributable to common stockholders of $63.3 million ($4.78 per diluted share) driven largely by a significant gain on sale of investment properties, alongside FFO and Core FFO declines year over year, the issuance of $100 million of 6.00% Series C Convertible Perpetual Preferred Stock led by Maewyn Capital Partners, initial investments in the seniors housing operating (SHOP) segment via the $249 million acquisition of two luxury communities in Alexandria, Virginia, and various joint venture, mezzanine loan, acquisition, and disposition activities including a $217 million sale of an inpatient rehabilitation facility portfolio into a new JV where Chiron retained a 15% interest; the supplemental also highlights modest same‑property cash NOI growth, leverage and covenant metrics, leadership team changes, and a tenant update on White Rock Medical Center’s Chapter 11 plan which currently contemplates affirming its lease with Chiron.

Filing Facts

CIK

1533615

Ticker

-

Form

8K

Source Type

sec

Accession

0001104659-26-091251

Alert Tier

7